Table 2.
Univariate Logistic Regression Analysis of Variables Related to Poor Adherence
| Variables | No. Pts | Poor Adherence | Good Adherence | Univariate Logistic Regression | ||
|---|---|---|---|---|---|---|
| OR | 95% CI | P value | ||||
| Age (years) | 96 | 62.41±13.03 | 53.73±11.36 | 1.065 | 1.019–1.114 | 0.005 |
| Male | 96 | 18/22 (81.80%) | 51/74 (68.90%) | 2.029 | 0.617–6.671 | 0.244 |
| Etiology of liver diseases | ||||||
| Hepatitis B virus | 96 | 12/22 (54.50%) | 34/74 (45.90%) | 1.569 | 0.590–4.170 | 0.367 |
| Hepatitis C virus | 96 | 2/22 (9.10%) | 8/74 (10.80%) | 0.868 | 0.170–4.438 | 0.865 |
| Alcohol abuse | 96 | 6/22 (27.30%) | 19/74 (25.70%) | 1.158 | 0.393–3.413 | 0.790 |
| Autoimmune liver diseases | 96 | 1/22 (4.50%) | 6/74 (8.10%) | 0.567 | 0.064–4.987 | 0.609 |
| History of endoscopic variceal treatment | 96 | 12/22 (54.50%) | 51/74 (68.90%) | 0.541 | 0.205–1.432 | 0.216 |
| History of using NSBBs | 96 | 8/22 (36.40%) | 44/74 (49.50%) | 0.390 | 0.146–1.043 | 0.061 |
| Child-Pugh score | 96 | 7.18±1.62 | 6.70±1.58 | 1.202 | 0.898-1.609 | 0.207 |
| MELD score | 96 | 11.41±4.64 | 10.99±3.39 | 1.023 | 0.902-1.161 | 0.720 |
| Primary prophylaxis | 96 | 5/22 (22.70%) | 9/74 (12.20%) | 2.124 | 0.629–7.171 | 0.225 |
| Secondary prophylaxis | 96 | 17/22 (77.30%) | 65/74 (87.80%) | 0.471 | 0.139–1.589 | 0.225 |
Note: The value in bold is defined as being statistically significant.
Abbreviations: Pts, patients; OR, odds ratio; CI, confidence interval; NSBBs, non-selective beta blockers; MELD, model for end-stage liver disease.